Zinforo (ceftaroline fosamil)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Community Acquired Pneumonia
Conditions
Community Acquired Pneumonia, Complicated Skin and Soft Tissue Infection
Trial Timeline
May 17, 2020 → Aug 30, 2021
NCT ID
NCT04198571About Zinforo (ceftaroline fosamil)
Zinforo (ceftaroline fosamil) is a pre-clinical stage product being developed by Pfizer for Community Acquired Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT04198571. Target conditions include Community Acquired Pneumonia, Complicated Skin and Soft Tissue Infection.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04198571 | Pre-clinical | Completed |
Competing Products
17 competing products in Community Acquired Pneumonia